NEW YORK, March 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Okta, Inc.
(NASDAQ:OKTA), Conduent Inc. (NYSE:CNDT), Innoviva, Inc. (NASDAQ:INVA), PRA Health Sciences, Inc. (NASDAQ:PRAH), DDR Corp.
(NYSE:DDR), and Tenet Healthcare Corporation (NYSE:THC), including updated fundamental summaries, consolidated fiscal reporting,
and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
OKTA DOWNLOAD: http://Fundamental-Markets.com/register/?so=OKTA
CNDT DOWNLOAD: http://Fundamental-Markets.com/register/?so=CNDT
INVA DOWNLOAD: http://Fundamental-Markets.com/register/?so=INVA
PRAH DOWNLOAD: http://Fundamental-Markets.com/register/?so=PRAH
DDR DOWNLOAD: http://Fundamental-Markets.com/register/?so=DDR
THC DOWNLOAD: http://Fundamental-Markets.com/register/?so=THC
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Okta,
Inc. (NASDAQ:OKTA), Conduent Inc. (NYSE:CNDT), Innoviva, Inc. (NASDAQ:INVA), PRA Health Sciences, Inc. (NASDAQ:PRAH), DDR Corp.
(NYSE:DDR), and Tenet Healthcare Corporation (NYSE:THC) on a fundamental level and outlines the overall demand for their products
and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going
forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. Please download the entire research report, free of
charge, to ensure you are reading all relevant material information. All information in this release was accessed March 2nd, 2018.
Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
OKTA, INC. (OKTA) REPORT OVERVIEW
Okta's Recent Financial Performance
For the three months ended October 31st, 2017 vs October 31st, 2016, Okta reported revenue of $68.24MM vs
$42.28MM (up 61.38%) and basic earnings per share -$0.35 vs -$1.14. For the twelve months ended January 31st, 2017 vs January 31st,
2016, Okta reported revenue of $160.33MM vs $85.91MM (up 86.63%) and basic earnings per share -$4.39 vs -$4.28. Okta is expected to
report earnings on March 7th, 2018. The report will be for the fiscal period ending January 31st, 2018. The estimated EPS forecast
for the next fiscal year is -$1.46 and is expected to report on March 7th, 2018.
To read the full Okta, Inc. (OKTA) report, download it here: http://Fundamental-Markets.com/register/?so=OKTA
-----------------------------------------
CONDUENT INC. (CNDT) REPORT OVERVIEW
Conduent's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Conduent reported revenue of
$1,480.00MM vs $1,596.00MM (down 7.27%) and basic earnings per share -$0.09 vs $0.01. For the twelve months ended December 31st,
2016 vs December 31st, 2015, Conduent reported revenue of $6,408.00MM vs $6,662.00MM (down 3.81%) and basic earnings per share
-$4.85 vs -$2.04. Conduent is expected to report earnings on May 9th, 2018. The report will be for the fiscal period ending March
31st, 2018. The reported EPS for the same quarter last year was $0.16. The estimated EPS forecast for the next fiscal year is $1.25
and is expected to report on February 20th, 2019.
To read the full Conduent Inc. (CNDT) report, download it here: http://Fundamental-Markets.com/register/?so=CNDT
-----------------------------------------
INNOVIVA, INC. (INVA) REPORT OVERVIEW
Innoviva's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Innoviva reported revenue of $69.52MM vs
$43.61MM (up 59.41%) and basic earnings per share $0.54 vs $0.23 (up 134.78%). For the twelve months ended December 31st, 2017 vs
December 31st, 2016, Innoviva reported revenue of $217.22MM vs $133.57MM (up 62.63%) and basic earnings per share $1.25 vs $0.54
(up 131.48%). Innoviva is expected to report earnings on April 26th, 2018. The report will be for the fiscal period ending March
31st, 2018. The reported EPS for the same quarter last year was $0.15. The estimated EPS forecast for the next fiscal year is $2.28
and is expected to report on February 14th, 2019.
To read the full Innoviva, Inc. (INVA) report, download it here: http://Fundamental-Markets.com/register/?so=INVA
-----------------------------------------
PRA HEALTH SCIENCES, INC. (PRAH) REPORT OVERVIEW
PRA Health Sciences' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, PRA Health Sciences reported revenue of
$655.90MM vs $472.39MM (up 38.85%) and basic earnings per share -$0.26 vs $0.23. For the twelve months ended December 31st, 2017 vs
December 31st, 2016, PRA Health Sciences reported revenue of $2,259.39MM vs $1,811.71MM (up 24.71%) and basic earnings per share
$1.39 vs $1.12 (up 24.11%). PRA Health Sciences is expected to report earnings on April 24th, 2018. The report will be for the
fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.60. The estimated EPS forecast for
the next fiscal year is $4.43 and is expected to report on February 20th, 2019.
To read the full PRA Health Sciences, Inc. (PRAH) report, download it here: http://Fundamental-Markets.com/register/?so=PRAH
-----------------------------------------
DDR CORP. (DDR) REPORT OVERVIEW
DDR's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, DDR reported revenue of $217.56MM vs
$240.26MM (down 9.45%) and basic earnings per share -$0.62 vs $0.07. For the twelve months ended December 31st, 2017 vs December
31st, 2016, DDR reported revenue of $921.59MM vs $1,005.81MM (down 8.37%) and basic earnings per share -$0.74 vs $0.10. DDR is
expected to report earnings on April 24th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS
for the same quarter last year was $0.30. The estimated EPS forecast for the next fiscal year is $0.99 and is expected to report on
February 21st, 2019.
To read the full DDR Corp. (DDR) report, download it here: http://Fundamental-Markets.com/register/?so=DDR
-----------------------------------------
TENET HEALTHCARE CORPORATION (THC) REPORT OVERVIEW
Tenet Healthcare's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Tenet Healthcare reported revenue of
$4,978.00MM vs $4,860.00MM (up 2.43%) and basic earnings per share -$2.28 vs -$0.79. For the twelve months ended December 31st,
2017 vs December 31st, 2016, Tenet Healthcare reported revenue of $19,179.00MM vs $19,621.00MM (down 2.25%) and basic earnings per
share -$7.00 vs -$1.93. Tenet Healthcare is expected to report earnings on May 7th, 2018. The report will be for the fiscal period
ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.27. The estimated EPS forecast for the next fiscal
year is $1.71 and is expected to report on February 25th, 2019.
To read the full Tenet Healthcare Corporation (THC) report, download it here: http://Fundamental-Markets.com/register/?so=THC
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA®
BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst®
(CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit
firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail
at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the
material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the
publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network
manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority,
Inc.
